Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| BRRProCap Financial, Inc. | $221.37M | — | $85K | — | -$28.98M | $15.34M | $92.55M | AI pending |
| HDSNHudson Technologies Inc | $221.6M | 26.6× | $246.61M | +4.0% | $16.67M | $25.6M | $4.76M | AI pending |
| STIMNeuronetics, Inc. | $221.73M | — | $149.16M | +99.2% | -$39M | $19.2M | $86.52M | AI pending |
| ANTXAN2 Therapeutics, Inc. | $221.89M | — | — | — | — | $44.32M | $13K | AI pending |
| DERMJourney Medical Corp | $221.99M | — | $61.24M | +11.1% | -$11.43M | $25.64M | $25.54M | AI pending |
| AMFNAmerican Fusion, Inc. | $222.29M | — | — | — | — | $79.34K | — | AI pending |
| YSGYatsen Holding Ltd | $222.31M | — | $614.62M | +32.2% | -$11.57M | $109.45M | $25.25M | AI pending |
| KROSKeros Therapeutics, Inc. | $222.46M | — | $244.06M | +6,775.0% | $87.01M | $257.61M | $15.72M | AI pending |
| DPRODraganfly Inc. | $222.52M | — | CA$7.73M | +17.8% | -CA$22.98M | CA$90.16M | CA$273.88K | AI pending |
| ONCH1RT Acquisition Corp. | $222.74M | 38.7× | — | — | — | $36.2K | — | AI pending |
| NEOVNeoVolta Inc. | $223.09M | — | $8.43M | +218.6% | -$5.03M | $11.48M | $1.45M | AI pending |
| HITIHigh Tide Inc. | $223.63M | — | CA$593.99M | +13.7% | -CA$51.4M | CA$47.88M | CA$63.24M | AI pending |
| SPOKSpok Holdings, Inc | $224.03M | 18.4× | $139.71M | +1.5% | $15.88M | $16.59M | $5.75M | AI pending |
| ABOSAcumen Pharmaceuticals, Inc. | $224.18M | — | — | — | — | $59.44M | $31.65M | Fair valued |
| TBCHTurtle Beach Corp | $224.23M | — | $319.91M | -14.2% | $15.73M | $19.57M | $80.69M | AI pending |
| NERVMinerva Neurosciences, Inc. | $224.41M | — | $0 | — | $1.44M | $24.65M | $16.29K | AI pending |
| DBHLDeep Isolation Nuclear, Inc. | $224.9M | — | $6.14M | -13.0% | -$5.34M | $19.38M | $226K | AI pending |
| TNXPTonix Pharmaceuticals Holding Corp. | $225.02M | — | $13.11M | +29.8% | -$124.02M | $176.23M | $1.27M | AI pending |
| SNDSmart Sand, Inc. | $225.35M | 21.0× | $330.15M | +6.0% | $1.35M | $10.2M | $43.55M | AI pending |
| RGCORgc Resources Inc | $225.69M | 16.1× | $93.89M | +16.6% | $13.28M | $2.47M | $148.79M | AI pending |